Dr Lars Riedemann is a physician-scientist trained in neurology and biomedical engineering. He is also a self-trained full-stack programmer and a consultant working at the intersection of healthcare and immersive technologies. Lars received his medical degree with summa cum laude from the University of Muenster, Germany. As a postdoctoral fellow, supported by the German Cancer Aid (Deutsche Krebshilfe), he conducted his research at the Massachusetts General Hospital (MGH) at Harvard Medical School (HMS) in close collaboration with the Massachusetts Institute of Technology (MIT).
He currently holds a position as a physician-scientist at the Department of Neurology at the Heidelberg University Hospital, the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) in Heidelberg, Germany. His current research focus is on brain tumors and biomedical imaging. Lars has co-authored several highly cited publications in leading scientific journals such as Cell, Proceedings of the National Academy of Sciences of the United States of America (PNAS), Nature Communications and Nature Biomedical Engeneering.
Lars has also co-founded Habilitas GbR, which was supported by the European Institute of Innovation & Technology (EIT), to develop an augmented reality product for patients suffering from aphasia.